Serum level of advanced oxidation protein products (AOPPs) in patients with Henoch–Schonlein purpura and its relationship with aberrant glycosylation of IgA1 and Cosmc mRNA expression
International Journal of Dermatology Jul 04, 2019
Liu Q, et al. - In this investigation involving 51 patients (aged 6 to 42 years), researchers examined the role of advanced oxidation protein products (AOPPs) in the pathogenesis of Henoch–Schonlein purpura (HSP), a type of leukocytoclastic vasculitis. According to results, serum levels of AOPPs in HSP patients and the HSP severity scores were positively correlated, implying that AOPPs could be used as one of the indicators for disease severity and prognosis during the course of the disease. In addition, it gives a theoretical basis for vitamin C, vitamin E, and other antioxidants to be used in the treatment of HSP. Overall, the authors concluded that AOPPs have an important role to play in HSP pathogenesis, particularly in patients of the renal type.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries